1. Home
  2. RGTI vs GKOS Comparison

RGTI vs GKOS Comparison

Compare RGTI & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rigetti Computing Inc.

RGTI

Rigetti Computing Inc.

HOLD

Current Price

$18.21

Market Cap

5.9B

Sector

Technology

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$143.04

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGTI
GKOS
Founded
2013
1998
Country
United States
United States
Employees
164
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
RGTI
GKOS
Price
$18.21
$143.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
$30.78
$126.92
AVG Volume (30 Days)
44.3M
1.0M
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
$225.06
$23.32
Revenue Next Year
$99.56
$27.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.33
52 Week Low
$11.14
$73.16
52 Week High
$58.15
$148.11

Technical Indicators

Market Signals
Indicator
RGTI
GKOS
Relative Strength Index (RSI) 41.48 67.61
Support Level $15.18 $130.04
Resistance Level $20.04 $147.43
Average True Range (ATR) 1.99 5.17
MACD -0.53 2.32
Stochastic Oscillator 7.09 93.16

Price Performance

Historical Comparison
RGTI
GKOS

About RGTI Rigetti Computing Inc.

Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: